Your browser doesn't support javascript.
loading
Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study.
Stacchiotti, S; Simeone, N; Lo Vullo, S; Morosi, C; Greco, F G; Gronchi, A; Barisella, M; Collini, P; Zaffaroni, N; Dagrada, G P; Frezza, A M; Mariani, L; Casali, P G.
Afiliação
  • Stacchiotti S; Medical Oncology Unit 2, Medical Oncology Department, Fondazione IRCCS Istituto Nazione dei Tumori, Milan, Italy. Electronic address: silvia.stacchiotti@istitutotumori.mi.it.
  • Simeone N; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Lo Vullo S; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Morosi C; Radiology Department, Fondazione IRCCS Istituto Nazione dei Tumori, Milan, Italy.
  • Greco FG; Radiology Department, Fondazione IRCCS Istituto Nazione dei Tumori, Milan, Italy.
  • Gronchi A; Sarcoma Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Barisella M; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Collini P; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Zaffaroni N; Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Dagrada GP; Diagnostic Pathology and Laboratory Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Frezza AM; Medical Oncology Unit 2, Medical Oncology Department, Fondazione IRCCS Istituto Nazione dei Tumori, Milan, Italy.
  • Mariani L; Unit of Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Casali PG; Medical Oncology Unit 2, Medical Oncology Department, Fondazione IRCCS Istituto Nazione dei Tumori, Milan, Italy; Medical Oncology and Hemato-Oncology Department, University of Milan, Milano, Italy.
Eur J Cancer ; 106: 225-233, 2019 01.
Article em En | MEDLINE | ID: mdl-30528807
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Inibidores de Proteínas Quinases / Tumores Fibrosos Solitários / Axitinibe Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores da Angiogênese / Inibidores de Proteínas Quinases / Tumores Fibrosos Solitários / Axitinibe Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2019 Tipo de documento: Article